Showing 27,301 - 27,320 results of 28,804 for search '(( 50 ((na decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( 12 wt decrease ))', query time: 0.97s Refine Results
  1. 27301

    DataSheet_1_Combined effects of exercise and immuno-chemotherapy treatments on tumor growth in MC38 colorectal cancer-bearing mice.docx by Manon Gouez (17969798)

    Published 2024
    “…TRT-EXE and EXE groups were submitted to 50 minutes of treadmill exercise before each treatment administration. …”
  2. 27302

    Data Sheet 1_Treatment with pemafibrate ameliorates fatty liver index and atherogenic lipid profiles in Japanese patients with type 2 diabetes mellitus.pdf by Toru Suzuki (512729)

    Published 2025
    “…There was no significant change in hemoglobin A1c level over time. FLI (mean ± standard deviation: 68.1 ± 21.9 vs. 39.6 ± 25.0, P < 0.001), but not FIB-4 index as a marker of hepatic fibrosis (median [interquartile range]: 1.04 [0.78-1.39] vs. 1.01 [0.68-1.36], P = 0.909), was significantly decreased by treatment with pemafibrate for 12M, and the proportion of patients with metabolic dysfunction-associated SLD (MASLD) was significantly decreased from 92.3% (baseline) to 61.5% (12M).…”
  3. 27303

    Classification of slope stability states. by Yongqing Zeng (8341515)

    Published 2024
    “…As the slope height increases from 5m to 45m, the safety factor of soil slope gradually decreases from 2.21 to 0.94; As the slope gradient increases from 20° to 60°, the safety factor of soil slope decreases approximately linearly from 1.80 to 0.95; As the cohesion of soil increases from 10kpa to 30kpa, the safety factor of soil slope increases approximately linearly from 1.04 to 1.60; As the internal friction angle of soil increases from 10° to 30°, the safety factor of soil slope increases approximately linearly from 1.00 to 1.81; As the unit weight of soil increases from 13kN/m<sup>3</sup> to 21kN/m<sup>3</sup>, the safety factor of soil slope decreases approximately linearly from 1.50 to 1.21. …”
  4. 27304

    The main calculation parameters of slope soil. by Yongqing Zeng (8341515)

    Published 2024
    “…As the slope height increases from 5m to 45m, the safety factor of soil slope gradually decreases from 2.21 to 0.94; As the slope gradient increases from 20° to 60°, the safety factor of soil slope decreases approximately linearly from 1.80 to 0.95; As the cohesion of soil increases from 10kpa to 30kpa, the safety factor of soil slope increases approximately linearly from 1.04 to 1.60; As the internal friction angle of soil increases from 10° to 30°, the safety factor of soil slope increases approximately linearly from 1.00 to 1.81; As the unit weight of soil increases from 13kN/m<sup>3</sup> to 21kN/m<sup>3</sup>, the safety factor of soil slope decreases approximately linearly from 1.50 to 1.21. …”
  5. 27305

    The mouse <i>Char10</i> locus regulates severity of pyruvate kinase deficiency and susceptibility to malaria by Aurélie Laroque (4034021)

    Published 2017
    “…Char10C mice also display a reduction in anemia phenotypes associated with the <i>Pklr</i><sup><i>G338D</i></sup> mutation including decreased splenomegaly, decreased circulating reticulocytes, increased density of mature erythrocytes, increased hematocrit, as well as decreased iron overload in kidney and liver and decreased serum iron. …”
  6. 27306

    Supplementary Material for: Comparison of Postoperative Neurocognitive Function in Older Adult Patients with and without Diabetes Mellitus by vanZuylen M.L. (12761705)

    Published 2022
    “…There were no between-group differences in mild or major POCD. Higher preoperative HbA1c levels were significantly correlated with decreased 30-day Δcognition scores (<i>F</i>(1, 54) = 9.4, <i>p</i> = 0.003) with an <i>R</i><sup>2</sup> of 0.149 (β −0.45, 95% confidence interval: −0.735 to −0.154). …”
  7. 27307

    Figure 6 from PD-1 Blockade Mitigates Surgery-Induced Immunosuppression and Increases the Efficacy of Photodynamic Therapy for Pleural Mesothelioma by Gwendolyn M. Cramer (16964052)

    Published 2025
    “…<b>A,</b> In AB12 mice, more than 50% of both PDT alone (<i>n</i> = 14) and PDT/aPD-1 (<i>n</i> = 12) had median survival (time to 400 mm<sup>3</sup>) greater than 90 days, and no differences between groups were detected (<i>P</i> = 0.56). …”
  8. 27308

    Data_Sheet_1_Hybrid Nanoparticles as an Efficient Porphyrin Delivery System for Cancer Cells to Enhance Photodynamic Therapy.pdf by Letícia B. Silva (11447653)

    Published 2021
    “…<p>Photodynamic therapy (PDT) is a potential non-invasive approach for application in oncological diseases, based on the activation of a photosensitizer (PS) by light at a specific wavelength in the presence of molecular oxygen to produce reactive oxygen species (ROS) that trigger the death tumor cells. …”
  9. 27309

    Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer by Takashi Hirosawa (5931845)

    Published 2018
    “…Sanger sequencing revealed a loss-of-function mutation of <i>BAP1</i> in 11 out of these 22 GBC cases (50%) with low BAP1 expression, whereas 2 out of 25 GBC cases (8%) were detected in cases with high BAP1 expression. …”
  10. 27310

    Image_4_Hybrid Nanoparticles as an Efficient Porphyrin Delivery System for Cancer Cells to Enhance Photodynamic Therapy.TIF by Letícia B. Silva (11447653)

    Published 2021
    “…<p>Photodynamic therapy (PDT) is a potential non-invasive approach for application in oncological diseases, based on the activation of a photosensitizer (PS) by light at a specific wavelength in the presence of molecular oxygen to produce reactive oxygen species (ROS) that trigger the death tumor cells. …”
  11. 27311

    Kisspeptin expression by human term placenta. by Zahra Rasoulzadeh (2622283)

    Published 2016
    “…KPs: Kisspeptin, CK7: Cytokeratin 7, TP: Term placenta, FTP: First trimester placenta, NC: Negative control. Scale bar: A; 100 μm, B; 50μm.</p>…”
  12. 27312

    Image_5_Hybrid Nanoparticles as an Efficient Porphyrin Delivery System for Cancer Cells to Enhance Photodynamic Therapy.TIF by Letícia B. Silva (11447653)

    Published 2021
    “…<p>Photodynamic therapy (PDT) is a potential non-invasive approach for application in oncological diseases, based on the activation of a photosensitizer (PS) by light at a specific wavelength in the presence of molecular oxygen to produce reactive oxygen species (ROS) that trigger the death tumor cells. …”
  13. 27313

    Data_Sheet_1_Protein and Signaling Pathway Responses to rhIL-6 Intervention Before Lobaplatin Treatment in Osteosarcoma Cells.PDF by Huan Wang (109286)

    Published 2021
    “…The immunofluorescence staining results were in accord with the immunohistochemistry staining results. siRNA knockdown of FUBP1 showed a strikingly decreased IC50 value for lobaplatin in FUBP1-silenced cells, which verified the role of FUBP1 in the drug susceptibility of osteosarcoma and the potential therapeutic value for increasing the sensitivity to lobaplatin. …”
  14. 27314

    Image_2_Hybrid Nanoparticles as an Efficient Porphyrin Delivery System for Cancer Cells to Enhance Photodynamic Therapy.TIF by Letícia B. Silva (11447653)

    Published 2021
    “…<p>Photodynamic therapy (PDT) is a potential non-invasive approach for application in oncological diseases, based on the activation of a photosensitizer (PS) by light at a specific wavelength in the presence of molecular oxygen to produce reactive oxygen species (ROS) that trigger the death tumor cells. …”
  15. 27315

    L-glutamate concentration-response relationships of SmGluCl-1:SmGluCl-2.1 and SmGluCl-1:SmGluCl-3 hetero-oligomers in <i>Xenopus</i> oocytes. by Vanessa Dufour (421400)

    Published 2013
    “…Co-injection of <i>SmGluCl-1</i> cRNA with <i>SmGluCl-2.1</i> cRNA decreased the response to glutamate compared to oocytes injected with <i>SmGluCl-2.1</i> cRNA alone (P<0.05, paired-T test), suggesting that SmGluCl-1 is a GluCl subunit and can form a heteromeric receptor with SmGluCl-2.1. …”
  16. 27316

    ERDRP-0519 potently inhibits <i>de novo</i> RNA synthesis. by Robert M. Cox (8029568)

    Published 2021
    “…<p><b>A-F)</b> Purified recombinant WT MeV L-P complexes or complexes harboring the L<sub>T776A</sub> or L<sub>H589Y</sub> resistance mutations were incubated with either a 16-nt RNA template (A) and the represented NTPs to assess <i>de novo</i> RNA synthesis or a 16-nt RNA template (B), a 5’-phosphorylated 4-nt primer, and the represented NTPs to assess primer extension. …”
  17. 27317

    Single cell gene expression analysis demonstrates transcriptional variation in murine LT-HSCs. by Jason P. Glotzbach (216727)

    Published 2011
    “…Error bars represent standard deviations derived through bootstrapping over 100,000 iterations as previously described <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0021211#pone.0021211-Efron1" target="_blank">[50]</a>.…”
  18. 27318

    Image_1_Hybrid Nanoparticles as an Efficient Porphyrin Delivery System for Cancer Cells to Enhance Photodynamic Therapy.TIF by Letícia B. Silva (11447653)

    Published 2021
    “…<p>Photodynamic therapy (PDT) is a potential non-invasive approach for application in oncological diseases, based on the activation of a photosensitizer (PS) by light at a specific wavelength in the presence of molecular oxygen to produce reactive oxygen species (ROS) that trigger the death tumor cells. …”
  19. 27319

    Image_3_Hybrid Nanoparticles as an Efficient Porphyrin Delivery System for Cancer Cells to Enhance Photodynamic Therapy.TIF by Letícia B. Silva (11447653)

    Published 2021
    “…<p>Photodynamic therapy (PDT) is a potential non-invasive approach for application in oncological diseases, based on the activation of a photosensitizer (PS) by light at a specific wavelength in the presence of molecular oxygen to produce reactive oxygen species (ROS) that trigger the death tumor cells. …”
  20. 27320

    DataSheet1_Computational design of custom therapeutic cells to correct failing human cardiomyocytes.pdf by Andrew Tieu (14441499)

    Published 2023
    “…Using a genetic algorithm-based optimization approach, candidate cells were accepted if a root mean square error (RMSE) of less than 50% relative to healthy hCM was achieved for both action potential and calcium transient waveforms for the cell-treated HF cardiomyocyte, normalized to the untreated HF cardiomyocyte.…”